SCHEMBL4404544

SCHEMBL4404544

O=C(CCCCCO)NC1CCCCC1

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.78
HDAC3 O15379 2/20 0.71
HDAC1 Q13547 2/20 0.71
HDAC2 Q92769 2/20 0.71
HDAC10 Q969S8 2/20 0.71
HDAC11 Q96DB2 2/20 0.71
HDAC8 Q9BY41 2/20 0.71
HDAC6 Q9UBN7 2/20 0.71
NCOR2 Q9Y618 1/20 0.71
EPHX1 P07099 4/20 0.60
ALDH1A1 P00352 3/20 0.59
HPGD P15428 4/20 0.58
EPHX2 P34913 1/20 0.54
KMT2A Q03164 1/20 0.52
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8013586 0.98 SMN1; SMN2 (0.81) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL7693790 0.92 SMN1; SMN2 (0.77) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL25825789 0.92 SMN1; SMN2 (0.77) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL38658755 0.92 SMN1; SMN2 (0.91) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL7699918 0.90 SMN1; SMN2 (0.67) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL9337868 0.90 SMN1; SMN2 (0.95) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL28668503 0.90 SMN1; SMN2 (0.95) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL15480466 0.87 SMN1; SMN2 (0.81) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL15480396 0.85 HDAC1 (0.96) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10
SCHEMBL6549000 0.85 SMN1; SMN2 (0.84) SMN1; SMN2HDAC3HDAC1HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632911-B2 Liquid modified diphenylmethane diisocyanates BAYER MATERIALSCIENCE LLC (US) 2009-12-15 US claimed
WO-2008060411-A2 NEW LIQUID MODIFIED DIPHENYLMETHANE DIISOCYANATES BAYER MATERIALSCIENCE LLC (US) 2008-05-22 WO claimed
US-20080114186-A1 New liquid modified diphenylmetilane diisocyanates BAYER MATERIALSCIENCE LLC 2008-05-15 US claimed
US-7632911-B2 Liquid modified diphenylmethane diisocyanates BAYER MATERIALSCIENCE LLC (US) 2009-12-15 US disclosed
WO-2008060411-A2 NEW LIQUID MODIFIED DIPHENYLMETHANE DIISOCYANATES BAYER MATERIALSCIENCE LLC (US) 2008-05-22 WO disclosed
US-20080114186-A1 New liquid modified diphenylmetilane diisocyanates BAYER MATERIALSCIENCE LLC 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114186-A1 New liquid modified diphenylmetilane diisocyanates DDT, DIMT1, QDPR SMN1; SMN2 3226/4885HDAC3 2793/4885HDAC1 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.